Inspire Investing LLC Purchases 5,403 Shares of Medifast, Inc. (NYSE:MED)

Inspire Investing LLC grew its holdings in Medifast, Inc. (NYSE:MED) by 11.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 54,270 shares of the specialty retailer’s stock after purchasing an additional 5,403 shares during the quarter. Inspire Investing LLC owned approximately 0.50% of Medifast worth $956,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of MED. Quarry LP lifted its holdings in Medifast by 592.7% in the second quarter. Quarry LP now owns 2,667 shares of the specialty retailer’s stock valued at $58,000 after buying an additional 2,282 shares during the period. CWM LLC lifted its stake in shares of Medifast by 70.9% in the 3rd quarter. CWM LLC now owns 8,006 shares of the specialty retailer’s stock valued at $153,000 after purchasing an additional 3,322 shares during the period. Public Employees Retirement System of Ohio boosted its position in shares of Medifast by 1,161.8% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 9,766 shares of the specialty retailer’s stock worth $187,000 after purchasing an additional 8,992 shares during the last quarter. Nisa Investment Advisors LLC grew its stake in shares of Medifast by 2,308.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock worth $202,000 after purchasing an additional 10,967 shares during the period. Finally, SG Americas Securities LLC acquired a new stake in shares of Medifast during the third quarter worth $206,000. Institutional investors and hedge funds own 95.51% of the company’s stock.

Medifast Stock Up 1.5 %

Shares of NYSE MED opened at $15.55 on Friday. The firm has a 50 day moving average price of $17.81 and a 200 day moving average price of $18.55. The company has a debt-to-equity ratio of 0.06, a quick ratio of 2.55 and a current ratio of 3.11. The stock has a market cap of $170.12 million, a P/E ratio of 23.56 and a beta of 1.15. Medifast, Inc. has a 52-week low of $14.94 and a 52-week high of $57.41.

Medifast (NYSE:MED) last released its quarterly earnings data on Monday, November 4th. The specialty retailer reported $0.35 EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.50. The business had revenue of $140.16 million during the quarter, compared to analysts’ expectations of $135.45 million. Medifast had a net margin of 1.09% and a return on equity of 15.98%. During the same quarter in the prior year, the company earned $2.12 EPS. Analysts expect that Medifast, Inc. will post 1.68 EPS for the current year.

Analyst Ratings Changes

Separately, DA Davidson upgraded Medifast from an “underperform” rating to a “neutral” rating and raised their target price for the stock from $16.50 to $17.00 in a report on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.